AnodyneWiki

Sevoflurane

sevo
Sevoflurane
Molecular structure via molpic based on CDK
Physical properties
[]
200.05 g/mol [1]
Density1505 at 25 °C/D g/cm3 [1]
AppearanceLiquid [1]
Melting point< 25 °C [1]
Boiling point58.1-58.2 °C at 751 mm Hg; 585.5 °C at 760 mm Hg [1]
SolubilityVery slightly soluble [1]
2.8 [1]
Structural Identifiers
[]
C4H3F7O [1]
1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)propane [1]
C(OC(C(F)(F)F)C(F)(F)F)F [1]
InChI=1S/C4H3F7O/c5-1-12-2(3(6,7)8)4(9,10)11/h2H,1H2 [1]
InChIKeyDFEYYRMXOJXZRJ-UHFFFAOYSA-N [1]
Pharmacokinetics[]
Elimination half-life15 – 23 hours

Sevoflurane (also known as 1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane, Sevofluran, Ultane, Sevorane, Sevoflurano, Sojourn, MR6S4, sevoflo, Sevofluranum or Propane, 1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)-) is a substance of the ether class.

Chemistry

 []

Sevoflurane is a achiral mixture.

Pharmacology

In the () sevoflurane acts as a anesthetic (), anesthetics, general (), halogenated hydrocarbon () and sevoflurane ().[1]

 []

  • Australia: Sevoflurane is a S4 substance.
  • Brazil: Sevoflurane is a C1 substance.[3]
  • Canada: Sevoflurane is a prescription only substance.
  • United Kingdom: Sevoflurane is a prescription only substance.
  • United States: Sevoflurane is a prescription only substance.
  • European Union: Sevoflurane is a prescription only substance.

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 5206, Sevoflurane. Accessed August 24, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5206

  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Sevoflurane. UNII: 38LVP0K73A. Global Substance Registration System. Accessed August 24, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/38LVP0K73A

  3. Anvisa. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. March 31, 2023. Accessed August 24, 2026. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992